| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | UnitedHealth (NYSE:UNH): America's Health System Creates The Opportunity For The Largest Listed Health Care Company! | 17 | Stocks Down Under | ||
| Do | UnitedHealth Stock Testing Key Support as Earnings Loom | 2 | Schaeffer's Research | ||
| Do | Dear UnitedHealth Stock Fans, Mark Your Calendars for October 13 | 6 | Barchart.com | ||
| Do | UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock? | 4 | Zacks | ||
| UNITEDHEALTH GROUP INC CDR Aktie jetzt für 0€ handeln | |||||
| Do | UnitedHealth's P/E Has Reset. Is the Stock Finally Undervalued? | 9 | Insider Monkey | ||
| Mi | Chutes & Ladders-WellSpan unveils its next CEO; UnitedHealthcare names president | 5 | FierceHealthcare | ||
| Mi | SA analyst upgrades/downgrades: NVDA, UNH, CLSK, CAT | 40 | Seeking Alpha | ||
| Di | Texas AG Targets UnitedHealth: Probe Examines Alleged Bribes, Care Delays and Coverage Denials | 7 | Benzinga.com | ||
| Di | UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore | 10 | Zacks | ||
| Mo | Texas AG Ken Paxton launches investigations into UnitedHealth Group, BCBSTX | 5 | FierceHealthcare | ||
| Mo | Roundhill UNH WeeklyPay ETF announces weekly distribution of $0.2812 | 6 | Seeking Alpha | ||
| Mo | Texas: Generalstaatsanwalt ermittelt gegen UnitedHealth wegen Leistungsverweigerung | 8 | Investing.com Deutsch | ||
| So | UnitedHealthcare, Aetna Tighten Medicare Advantage Networks as 2027 Costs Rise: 'We Can't Ignore the Realities…' | 11 | Benzinga.com | ||
| So | PAUKENSCHLAG: Steht die Unitedhealth-Aktie vor einer Kursexplosion? - Handeln Sie vor Montag! | Hebelschein-Spekulant | |||
| Sa | UnitedHealth Reports on Oct. 13. Here's the 1 Number I'm Watching. | 20 | The Motley Fool | ||
| 02.10. | Debunked Episode 30: ACCESS Tries to Succeed Where VBC Fails, AI, and UnitedHealth Gets the Last Week Tonight Treatment | 6 | MedCity News | ||
| 01.10. | UnitedHealthcare Rolls Out 2027 Medicare Plans With $0 Premiums, Drug Copays And Broader Benefits | 8 | Benzinga.com | ||
| 01.10. | UnitedHealthcare Unveils FY27 Medicare Advantage Plans | 551 | AFX News | MINNETONKA (dpa-AFX) - Health care and well-being major UnitedHealth Group Inc. (UNH) Thursday introduced its 2027 Medicare Advantage plans, focused on affordability, simplicity and a more connected... ► Artikel lesen | |
| 01.10. | UnitedHealthcare stellt Medicare Advantage-Tarife für 2027 vor | 11 | Investing.com Deutsch | ||
| 01.10. | UnitedHealthcare unveils 2027 Medicare Advantage plans | 10 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| M1 KLINIKEN | 20,000 | -0,50 % | Drohnenauftrag für Volatus, KI-Strom treibt Infineon und Beauty-Boom bei M1 Kliniken: Drei spannende Aktien im Check | Drohnen fürs kanadische Militär, Chips für den KI-Boom und Schönheitsbehandlungen mit satten Margen: Börsenfantasie hat viele Gesichter. Volatus Aerospace könnte mit einem kanadischen Militärauftrag... ► Artikel lesen | |
| GT BIOPHARMA | 6,045 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma | FDA clearance of a new IND for GTB-5550 in multiple myeloma (MM) under an investigator sponsored trial (IST) protocol Initiation of Phase 1 trial in MM patients contingent upon timing and receipt... ► Artikel lesen | |
| AETHLON MEDICAL | 6,010 | 0,00 % | Aethlon Medical +564%: NBC-Empfehlung explodiert und lässt Mitglieder triumphieren | Die Microcap-Aktie von Aethlon Medical sorgt mit einem Kurssprung von satten +564 % für weltweites Aufsehen - und beschert Anlegern des No Brainer Club damit einen weiteren Mega-Volltreffer. Auslöser... ► Artikel lesen | |
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab | ||
| FRESENIUS | 42,510 | +2,21 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| HEARTFLOW | 47,590 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,640 | +2,51 % | FMC bekommt neuen CEO - Shervin J. Korangy folgt auf Helen Giza | DJ FMC bekommt neuen CEO - Shervin J. Korangy folgt auf Helen Giza
DOW JONES--Fresenius Medical Care (FMC) wechselt überraschend den CEO aus. Wie der DAX-Konzern mitteilte, beschloss der Aufsichtsrat... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| AVEANNA HEALTHCARE | 12,235 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | 0,00 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,060 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call |